Caretaker Medical Receives New Investment From Philips and Others to Enhance Wireless 'Beat by Beat' Blood Pressure and Continuous Vital Signs Platform for Remote and 'Clinically-Distanced' Patient Monitoring
Summary
Caretaker Medical, a leader in clinical-grade wireless patient monitoring and maker of the Caretaker® wearable patient monitor that utilizes a simple Finger Cuff to remotely measure “Beat by Beat” Continuous Blood Pressure and multiple vital signs has announced the completion of a Series B funding round from new investors Philips and Ming Capital, with participation from existing investors including IrishAngels, Felton Group, and others. During their participation in our start-up acceleration program, we were impressed by Caretaker’s innovative approach to wireless, continuous patient monitoring in various high acuity settings in the hospital. We look forward to collaborating together on an integrated solution that helps hospitals and health systems achieve the quadruple-aim of improved outcomes, enhanced patient and staff experience, and lower costs.” Jeff Pompeo, President & CEO of Caretaker Medical added, “We are excited to have Philips and Ming Capital join our investor group, and grateful for the continued strong support from our existing investors. We’re particularly pleased to be collaborating with market leader Philips, with whom we share a passion for creating digital health innovations that improve lives, and we look forward to working closely together. The CareTaker patented technology delivers “ICU Quality” continuous measurements without intrusive arterial catheters or cumbersome wires, giving clinicians the ability to recognize deteriorating hemodynamic trends earlier for faster interventions while providing a more comprehensive view of patient vital signs status.
